RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E

Watchlist Manager
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Logo
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Watchlist
Price: 2.67 TRY 0.75% Market Closed
Market Cap: 1.3B TRY

Net Margin
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

126.8%
Current
108%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
126.8%
=
Net Income
267.2m
/
Revenue
210.8m

Net Margin Across Competitors

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
Glance View

Market Cap
1.3B TRY
Industry
Biotechnology

RTA Laboratuvarlari Biyolojik Ürünler Ilaç ve Makine Sanayi Ticaret AS engages in the production, research, and development in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.

RTALB.E Intrinsic Value
1.94 TRY
Overvaluation 27%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
126.8%
=
Net Income
267.2m
/
Revenue
210.8m
What is the Net Margin of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS?

Based on RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's most recent financial statements, the company has Net Margin of 126.8%.

Back to Top